Basic Information (Switzerland) Elecon Asia SA (hereinafter referred to as “Elecon”) is a powerful intelligent three-d...
Digital Copyright Ten Major Typical Cases 1.Short Video Copyright Case: Whether a Short Video is Original Has Nothing to...
December 7, 2023 - News of a patent infringement ruling against Apple Watches a few weeks ago caused a flurry of investo...
the patents likely valid, which may have prompted the swift infringement ruling in Munich. However, the Federal Patent Court will not rule on the patents’ validity until summer 2026. First injunction
products in the Netherlands, France, Germany, and Italy, where EP 936 was previously valid. After Hurom lodged the infringement action in Paris, NUC and Warmcook filed a counterclaim for revocation
has gained a reputation as an interesting venue for preliminary injunctions. According to the UPC’s latest statistics, Lisbon has heard one infringement claim and two preliminary injunction cases. It
’ withdrawal of its infringement suits suggests that Bruker can continue selling its CosMx Spatial Molecular Imager instruments and CosMx reagents for RNA detection. Bruker acquired the products from
Co., Ltd., against its rival Zhejiang Gonda Electronic Technology Co., Ltd., for patent infringement. The lawsuit, filed in the Zhejiang High People's Court, seeks RMB 200 million in damages, as
PARIS, Nov 12 (Reuters) - Major French newspapers, including Le Monde, Le Figaro and Le Parisien, said on Tuesday that they were taking legal action against social media platform X for allegedly using...
Meihua Group, China’s largest monosodium glutamate (MSG) producer, has been sued by Japan’s Ajinomoto Co. for alleged patent infringement concerning core amino acid production technologies. The case
patent, constituting contributory infringement. [Keywords] Civil, Infringement of Invention Patent Right, Contributory Infringement, Combination of Components [Basic Facts of the Case] Plaintiff Japanese
On July 21, 2025, the Hangzhou Intermediate People's Court issued a landmark second-instance decision in a trademark infringement and unfair competition case involving the "G. Patton" brand
Biogen may not use a specific composition with the monoclonal antibody adalimumab in its anti-rheumatic drug Imraldi, marketed in Germany. Düsseldorf Higher Regional Court found Biogen's biosimilar i...
CHINA intellectual PROPERTY LAWYERS NETWORK
+86-13910160652
ciplawyers@163.com
